HTT and Huntington disease: Hence, therapeutic approaches for the treatment of HD besides targeting HTT comprise targeting of TAU similar to AD, including modulation of MAPT gene expression, inhibition of TAU aggregation, targeting hyperphosphorylated TAU, and TAU immunotherapies [219].